Lymphocyte transformation with streptolysin S preparations and inhibition of streptolysin S by serum in rheumatic fever and other rheumatic diseases.
D000293:Adolescent; D000328:Adult; D000989:Antistreptolysin / Q000494:pharmacology*; D001171:Arthritis, Juvenile / Q000276:immunology; D001172:Arthritis, Rheumatoid / Q000276:immunology; D003470:Culture Media; D005260:Female; D005921:Glomerulonephritis / Q000276:immunology; D006801:Humans; D037102:Lectins / Q000494:pharmacology; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012216:Rheumatic Diseases / Q000276:immunology*; D012213:Rheumatic Fever / Q000276:immunology*; D012595:Scleroderma, Systemic / Q000276:immunology; D013166:Spondylitis / Q000276:immunology; D013301:Streptolysins / Q000494:pharmacology*; D013997:Time Factors
D003470:Culture Media; D037102:Lectins; D013301:Streptolysins; D000989:Antistreptolysin